1. Home
  2. APLS vs OUT Comparison

APLS vs OUT Comparison

Compare APLS & OUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • OUT
  • Stock Information
  • Founded
  • APLS 2009
  • OUT 2013
  • Country
  • APLS United States
  • OUT United States
  • Employees
  • APLS N/A
  • OUT N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • OUT Real Estate Investment Trusts
  • Sector
  • APLS Health Care
  • OUT Real Estate
  • Exchange
  • APLS Nasdaq
  • OUT Nasdaq
  • Market Cap
  • APLS 3.5B
  • OUT 3.2B
  • IPO Year
  • APLS 2017
  • OUT N/A
  • Fundamental
  • Price
  • APLS $25.17
  • OUT $18.89
  • Analyst Decision
  • APLS Buy
  • OUT Buy
  • Analyst Count
  • APLS 20
  • OUT 7
  • Target Price
  • APLS $34.11
  • OUT $19.44
  • AVG Volume (30 Days)
  • APLS 2.1M
  • OUT 1.6M
  • Earning Date
  • APLS 11-04-2025
  • OUT 11-11-2025
  • Dividend Yield
  • APLS N/A
  • OUT 6.43%
  • EPS Growth
  • APLS N/A
  • OUT N/A
  • EPS
  • APLS N/A
  • OUT 0.60
  • Revenue
  • APLS $754,649,000.00
  • OUT $1,796,000,000.00
  • Revenue This Year
  • APLS $20.59
  • OUT N/A
  • Revenue Next Year
  • APLS N/A
  • OUT $2.79
  • P/E Ratio
  • APLS N/A
  • OUT $31.09
  • Revenue Growth
  • APLS 20.02
  • OUT N/A
  • 52 Week Low
  • APLS $16.10
  • OUT $12.95
  • 52 Week High
  • APLS $39.51
  • OUT $19.98
  • Technical
  • Relative Strength Index (RSI)
  • APLS 44.82
  • OUT 57.16
  • Support Level
  • APLS $27.26
  • OUT $18.50
  • Resistance Level
  • APLS $28.97
  • OUT $19.11
  • Average True Range (ATR)
  • APLS 0.99
  • OUT 0.47
  • MACD
  • APLS -0.58
  • OUT -0.03
  • Stochastic Oscillator
  • APLS 11.00
  • OUT 88.62

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About OUT OUTFRONT Media Inc.

Outfront Media Inc is a real estate investment trust involved in the ownership of advertising space on its portfolio of billboards and transit displays. The Company generates revenue in the form of rental income by allowing other companies to advertise on its properties and structures under short-term contracts. Outfront Media segments its operations into the United States and International units. Although it also owns assets in Canada and Latin America, the company derives the vast majority of its revenue from billboard advertising agreements in the U.S. Roughly half of the U.S. division's revenue comes from its displays in the New York City and Los Angeles markets. Outfront Media's customers include entities within the retail, television, healthcare, and entertainment industries.

Share on Social Networks: